Metronomia Clinical Research GMBH   Report issue

For profit Phase 1 Phase 2
Founded: Munich Germany (1990)

Organization Overview

First Clinical Trial
2015
NCT02557633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Metronomia | Metronomia Clinical Research GMBH

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis (Phase 2)

Glomerulonephritis, Membranous (Phase 2)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Rhinitis, Allergic, Seasonal (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3